B. Riley Issues Positive Forecast for Lam Research Earnings

Lam Research Co. (NASDAQ:LRCX) – Research analysts at B. Riley increased their Q3 2025 earnings estimates for shares of Lam Research in a report released on Thursday, January 30th. B. Riley analyst C. Ellis now anticipates that the semiconductor company will post earnings per share of $0.98 for the quarter, up from their previous forecast of $0.85. B. Riley has a “Buy” rating and a $105.00 price objective on the stock. The consensus estimate for Lam Research’s current full-year earnings is $3.69 per share. B. Riley also issued estimates for Lam Research’s Q2 2026 earnings at $0.80 EPS, Q3 2026 earnings at $0.80 EPS, Q4 2026 earnings at $0.87 EPS and FY2026 earnings at $3.30 EPS.

Several other brokerages also recently commented on LRCX. Morgan Stanley boosted their target price on Lam Research from $76.00 to $78.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 5th. Cantor Fitzgerald upgraded shares of Lam Research from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $95.00 to $100.00 in a research report on Thursday, January 30th. Sanford C. Bernstein upgraded Lam Research from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $85.00 to $91.00 in a report on Thursday, January 30th. The Goldman Sachs Group cut their price target on Lam Research from $96.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Finally, BNP Paribas upgraded shares of Lam Research to a “hold” rating in a research note on Thursday, October 24th. Seven equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $95.72.

Lam Research Price Performance

Lam Research stock opened at $79.91 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. Lam Research has a 52 week low of $68.87 and a 52 week high of $113.00. The stock has a market capitalization of $102.82 billion, a P/E ratio of 24.27, a price-to-earnings-growth ratio of 1.34 and a beta of 1.46. The stock has a fifty day moving average of $76.18 and a 200-day moving average of $78.44.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%.

Institutional Trading of Lam Research

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Migdal Insurance & Financial Holdings Ltd. boosted its position in shares of Lam Research by 2,400.0% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 200 shares of the semiconductor company’s stock valued at $163,000 after buying an additional 192 shares during the last quarter. Sunflower Bank N.A. purchased a new position in Lam Research during the 3rd quarter worth $202,000. Insight Wealth Partners LLC bought a new stake in shares of Lam Research in the 3rd quarter worth $202,000. B&L Asset Management LLC purchased a new stake in shares of Lam Research in the third quarter valued at about $204,000. Finally, CWC Advisors LLC. bought a new position in shares of Lam Research during the third quarter valued at about $220,000. 84.61% of the stock is owned by institutional investors.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.